Chloroquine (Emqui-DS (500mg)) is used for the treatment of Malaria, Rheumatoid Arthritis, Lupus Erythematosus & COVID-19 Infection.
Mechanism of action: It acts by blocking the action of enzyme ‘heme polymerase’ in malarial parasites and this leads to accumulation of heme - which is toxic to the malarial parasite. This leads to the death of the malarial parasite.
Update:
•FDA warns against the use of Chloroquine (Emqui-DS (500mg)) or hydroxyChloroquine (Emqui-DS (500mg)) for treating COVID-19 outside the hospital setting or a clinical trial due to high risk of heart rhythm issues.
• Chloroquine (Emqui-DS (500mg)) and hydroxyChloroquine (Emqui-DS (500mg)) gained attention in spite of sayings by the World Health Organization (WHO) that there is no definitive evidence they work for COVID-19 patients.
• Larger, high-quality randomized clinical trials may be needed in order to precisely evaluate its effectiveness, according to University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19.
• More than 20 trials are being carried out on Chloroquine (Emqui-DS (500mg)) for treating COVID-19 in the US, UK, Spain, and China.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Generic : Chloroquine
Price Updated on August 08, 2019
Mechanism of action: It acts by blocking the action of enzyme ‘heme polymerase’ in malarial parasites and this leads to accumulation of heme - which is toxic to the malarial parasite. This leads to the death of the malarial parasite.
Update:
•FDA warns against the use of Chloroquine (Emqui-DS (500mg)) or hydroxyChloroquine (Emqui-DS (500mg)) for treating COVID-19 outside the hospital setting or a clinical trial due to high risk of heart rhythm issues.
• Chloroquine (Emqui-DS (500mg)) and hydroxyChloroquine (Emqui-DS (500mg)) gained attention in spite of sayings by the World Health Organization (WHO) that there is no definitive evidence they work for COVID-19 patients.
• Larger, high-quality randomized clinical trials may be needed in order to precisely evaluate its effectiveness, according to University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19.
• More than 20 trials are being carried out on Chloroquine (Emqui-DS (500mg)) for treating COVID-19 in the US, UK, Spain, and China.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Emqui-DS (500mg) - Merck Ltd. (India)
Emqui-DS (500mg) Film coated tablet
Generic : Chloroquine
₹
6.2
500mg
5
Substitute/Alternative Medication to Emqui-DS (500mg)
Amoquin | Amoquin (250 mg) | Antima | Apaquine | Arquin | Arquin (450 ml) | Arquin (60 ml) | Bitaquine | Bitaquine (10ml) | Bitaquine (30 ml)
When is Emqui-DS (500mg) prescribed?
It is prescribed for -
